Jonathan S. Goldberg

1.2k citations
11 papers · 960 indexed · 1 hit paper · h-index 9
Topics
Retinoids in leukemia and cellular processes (2 papers)Peptidase Inhibition and Analysis (2 papers)Ubiquitin and proteasome pathways (2 papers)

In The Last Decade

Jonathan S. Goldberg

10 papers receiving 939 citations

Hit Papers

First-Line Gefitinib in Patients With Advanced Non–Small-...20082026201420202008200400600

Peers

Jonathan S. Goldberg
Comparison fields: 5 of 71
  • Pulmonary and Respiratory Medicine 597
  • Oncology 527
  • Molecular Biology 359
  • Cancer Research 199
  • Surgery 107
Replace Anne Offermann with:
Anne Offermann Germany
E. Edmund Kim United States
Yangzi Tian China
J Simony-Lafontaine France
Nikolaos Xenidis Greece
Naixin Liang China
Zhenbin Shen China
Tetsukan Woo Japan
S. A. Vaziri United States
Jonathan S. Goldberg relative to Anne Offermann Germany Anne Offermann's profile →
Citations per field
00.5×5.4×
Anne Offermann · 1×
Citations per year

Countries citing papers authored by Jonathan S. Goldberg

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Goldberg more than expected).

Fields of papers citing papers by Jonathan S. Goldberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Goldberg. The network helps show where Jonathan S. Goldberg may publish in the future.

Co-authorship network of co-authors of Jonathan S. Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Goldberg. A scholar is included among the top collaborators of Jonathan S. Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Goldberg. Jonathan S. Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 18
3 67
4 18
5
First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutationsbreakdown →
661
6 65
7 20
8 19
9
Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
49
10
Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
35
11
Recommandations pour une bonne pratique dans la prise en charge de la douleur du cancer chez l'adulte et l'enfant
8

About Jonathan S. Goldberg

Jonathan S. Goldberg is a scholar working on Toxicology, Dermatology and Oncology, having authored 11 papers that have together received 960 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (527 citations), Pulmonary and Respiratory Medicine (597 citations) and Cancer Research (199 citations). Jonathan S. Goldberg has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Jeffrey A. Engelman, Victoria A. Joshi, Lecia V. Sequist, A. John Iafrate, Bruce E. Johnson, Daniel A. Haber, David McCollum, Georgiana Kuhlmann, Alona Muzikansky and Pasi A. Jänne. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026